Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients

Journal of Hepatology

Volumn 59, Issue 3, 2013, Pages 427-433

  Glässner, Andreas ^a   Eisenhardt, Marianne ^a   Kokordelis, Pavlos ^a   Krämer, Benjamin ^a   Wolter, Franziska ^a   Nischalke, Hans Dieter ^a   Boesecke, Christoph ^a   Sauerbruch, Tilman ^a   Rockstroh, Jürgen K ^a   Spengler, Ulrich ^a   Nattermann, Jacob ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; CD4+ T cells; Hepatic stellate cells; HIV HCV co infection; IL 2; Liver fibrosis; NK cells; NKG2D

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NATURAL KILLER CELL; PRIORITY JOURNAL; STELLATE CELL;

APOPTOSIS; CD4(+) T CELLS; FACS; FBS; FETAL BOVINE SERUM; FLUORESCENCE-ACTIVATED CELL SORTING; HCV; HEPATIC STELLATE CELLS; HEPATITIS C VIRUS; HIV; HIV/HCV CO-INFECTION; HSC; HUMAN IMMUNODEFICIENCY VIRUS; IFN; IL; IL-2; INTERFERON; INTERLEUKIN; LIVER FIBROSIS; NATURAL KILLER CELL; NK CELL; NK CELLS; NKG2D; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; SIV; STECM; STELLATE CELL MEDIUM; TRAIL; TUMOUR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; CASE-CONTROL STUDIES; COCULTURE TECHNIQUES; COINFECTION; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84882845968     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.04.029     Document Type: Article

References (40)

1. K. Lacombe, and J. Rockstroh HIV and viral hepatitis coinfections: advances and challenges Gut 61 2012 i47 i58
2. M. Winnock, D. Salmon-Ceron, F. Dabis, and G. Chene Interaction between HIV-1 and HCV infections: towards a new entity? J Antimicrob Chemother 53 2004 936 946
3. Y. Benhamou, M. Bochet, V. Di Martino, F. Charlotte, F. Azria, and A. Coutellier Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group Hepatology 30 1999 1054 1058
4. P. Martin, A.M. Di Bisceglie, C. Kassianides, M. Lisker-Melman, and J.H. Hoofnagle Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection Gastroenterology 97 1989 1559 1561
5. J.K. Rockstroh, U. Spengler, T. Sudhop, S. Ewig, A. Theisen, and U. Hammerstein Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV Am J Gastroenterol 91 1996 2563 2568
6. R. Bruno, S. Galastri, P. Sacchi, S. Cima, A. Caligiuri, and R. DeFranco Gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis Gut 59 2010 513 520
7. F. Hong, Y. Saiman, C. Si, A. Mosoian, and M.B. Bansal X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4 PLoS One 7 2012 e33659
8. A.C. Tuyama, F. Hong, Y. Saiman, C. Wang, D. Ozkok, and A. Mosoian Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis Hepatology 52 2010 612 622
9. Y. Benhamou, V. Di Martino, M. Bochet, G. Colombet, V. Thibault, and A. Liou Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy Hepatology 34 2001 283 287
10. N. Brau, M. Salvatore, C.F. Rios-Bedoya, A. Fernandez-Carbia, F. Paronetto, and J.F. Rodriguez-Orengo Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy J Hepatol 44 2006 47 55
11. V. Di Martino, P. Rufat, N. Boyer, P. Renard, F. Degos, and M. Martinot-Peignoux The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study Hepatology 34 2001 1193 1199
12. A.H. Mohsen, P.J. Easterbrook, C. Taylor, B. Portmann, R. Kulasegaram, and S. Murad Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients Gut 52 2003 1035 1040
13. N. Qurishi, C. Kreuzberg, G. Luchters, W. Effenberger, B. Kupfer, and T. Sauerbruch Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
14. M. Schiavini, E. Angeli, A. Mainini, C. Uberti-Foppa, P. Zerbi, and C. Sagnelli Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients Hepat Mon 11 2011 525 531
15. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annu Rev Immunol 7 1989 145 173
16. T.A. Fehniger, M.A. Cooper, G.J. Nuovo, M. Cella, F. Facchetti, and M. Colonna CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity Blood 101 2003 3052 3057
17. X.S. He, M. Draghi, K. Mahmood, T.H. Holmes, G.W. Kemble, and C.L. Dekker T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus J Clin Invest 114 2004 1812 1819
18. A. Horowitz, R.H. Behrens, L. Okell, A.R. Fooks, and E.M. Riley NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination J Immunol 185 2010 2808 2818
19. A. Horowitz, J.C. Hafalla, E. King, J. Lusingu, D. Dekker, and A. Leach Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS, S/AS01 malaria vaccine J Immunol 188 2012 5054 5062
20. A. Horowitz, K.C. Newman, J.H. Evans, D.S. Korbel, D.M. Davis, and E.M. Riley Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes J Immunol 184 2010 6043 6052
21. M.B. McCall, M. Roestenberg, I. Ploemen, A. Teirlinck, J. Hopman, and Q. de Mast Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum Eur J Immunol 40 2010 3472 3477
22. D.A. Vargas-Inchaustegui, P. Xiao, I. Tuero, L.J. Patterson, and M. Robert-Guroff NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model J Immunol 198 2012 1878 1885
23. B. Gao, S. Radaeva, and W.I. Jeong Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis Exp Rev Gastroenterol Hepatol 1 2007 173 180
24. A. Glässner, M. Eisenhardt, B. Krämer, C. Körner, M. Coenen, and T. Sauerbruch NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner Lab Invest 92 2012 967 977
25. A. Melhem, N. Muhanna, A. Bishara, C.E. Alvarez, Y. Ilan, and T. Bishara Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC J Hepatol 45 2006 60 71
26. S. Radaeva, R. Sun, B. Jaruga, V.T. Nguyen, Z. Tian, and B. Gao Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners Gastroenterology 130 2006 435 452
27. S.L. Friedman Liver fibrosis - from bench to bedside J Hepatol 38 2003 S38 S53
28. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 539 548
29. U. Spengler, and J. Nattermann Immunopathogenesis in hepatitis C virus cirrhosis Clin Sci (Lond) 112 2007 141 155
30. W.I. Jeong, O. Park, Y.G. Suh, J.S. Byun, S.Y. Park, and E. Choi Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice Hepatology 53 2011 1342 1351
31. M. Coenen, H.D. Nischalke, B. Krämer, B. Langhans, A. Glässner, and D. Schulte Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2 Lab Invest 91 2011 1375 1382
32. M. Eisenhardt, A. Glässner, B. Krämer, C. Körner, B. Sibbing, and P. Kokordelis The CXCR3(+)CD56 bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C PLoS One 7 2012 e38846
33. B. Krämer, C. Körner, M. Kebschull, A. Glässner, M. Eisenhardt, and H.D. Nischalke Natural killer p46 high expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis Hepatology 56 2012 1201 1213
34. G. Alter, J.M. Malenfant, and M. Altfeld CD107a as a functional marker for the identification of natural killer cell activity J Immunol Methods 294 2004 15 22
35. C. Morishima, D.M. Paschal, C.C. Wang, C.S. Yoshihara, B.L. Wood, and A.E. Yeo Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing Hepatology 43 2006 573 580
36. A. Senik, S. Stefanos, J.P. Kolb, M. Lucero, and E. Falcoff Enhancement of mouse natural killer cell activity by type II interferon Ann Immunol (Paris) 131C 1980 349 361
37. G. Konjevic, K. Mirjacic Martinovic, A. Vuletic, and N. Babovic In-vitro IL-2 or IFN-alpha-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients Melanoma Res 20 2010 459 467
38. H. Song, D.Y. Hur, K.E. Kim, H. Park, T. Kim, and C.W. Kim IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway Cell Immunol 242 2006 39 45
39. C. Erikstrup, G. Kronborg, N. Lohse, S.R. Ostrowski, J. Gerstoft, and H. Ullum T cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication J Acquir Immune Defic Syndr 53 2010 303 310
40. S.R. Ostrowski, J. Gerstoft, B.K. Pedersen, and H. Ullum Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients Aids 17 2003 521 530